95 related articles for article (PubMed ID: 17160431)
1. Improved survival in BRCA2 carriers with ovarian cancer.
Pal T; Permuth-Wey J; Kapoor R; Cantor A; Sutphen R
Fam Cancer; 2007; 6(1):113-9. PubMed ID: 17160431
[TBL] [Abstract][Full Text] [Related]
2. Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
McLaughlin JR; Rosen B; Moody J; Pal T; Fan I; Shaw PA; Risch HA; Sellers TA; Sun P; Narod SA
J Natl Cancer Inst; 2013 Jan; 105(2):141-8. PubMed ID: 23257159
[TBL] [Abstract][Full Text] [Related]
3. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.
Candido-dos-Reis FJ; Song H; Goode EL; Cunningham JM; Fridley BL; Larson MC; Alsop K; Dicks E; Harrington P; Ramus SJ; de Fazio A; Mitchell G; Fereday S; Bolton KL; Gourley C; Michie C; Karlan B; Lester J; Walsh C; Cass I; Olsson H; Gore M; Benitez JJ; Garcia MJ; Andrulis I; Mulligan AM; Glendon G; Blanco I; Lazaro C; Whittemore AS; McGuire V; Sieh W; Montagna M; Alducci E; Sadetzki S; Chetrit A; Kwong A; Kjaer SK; Jensen A; Høgdall E; Neuhausen S; Nussbaum R; Daly M; Greene MH; Mai PL; Loud JT; Moysich K; Toland AE; Lambrechts D; Ellis S; Frost D; Brenton JD; Tischkowitz M; Easton DF; Antoniou A; Chenevix-Trench G; Gayther SA; Bowtell D; Pharoah PD; ; ;
Clin Cancer Res; 2015 Feb; 21(3):652-7. PubMed ID: 25398451
[TBL] [Abstract][Full Text] [Related]
4. Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.
Byrd LM; Shenton A; Maher ER; Woodward E; Belk R; Lim C; Lalloo F; Howell A; Jayson GC; Evans GD
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1535-42. PubMed ID: 18559571
[TBL] [Abstract][Full Text] [Related]
5. Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives.
Zimmer K; Kocher F; Puccini A; Seeber A
Front Oncol; 2021; 11():662055. PubMed ID: 34707985
[TBL] [Abstract][Full Text] [Related]
6. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
Carbone M; Adusumilli PS; Alexander HR; Baas P; Bardelli F; Bononi A; Bueno R; Felley-Bosco E; Galateau-Salle F; Jablons D; Mansfield AS; Minaai M; de Perrot M; Pesavento P; Rusch V; Severson DT; Taioli E; Tsao A; Woodard G; Yang H; Zauderer MG; Pass HI
CA Cancer J Clin; 2019 Sep; 69(5):402-429. PubMed ID: 31283845
[TBL] [Abstract][Full Text] [Related]
7. Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.
Huang YW
Medicine (Baltimore); 2018 Jan; 97(2):e9380. PubMed ID: 29480828
[TBL] [Abstract][Full Text] [Related]
8. Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.
Krivokuca A; Dragos VS; Stamatovic L; Blatnik A; Boljevic I; Stegel V; Rakobradovic J; Skerl P; Jovandic S; Krajc M; Magic MB; Novakovic S
Fam Cancer; 2018 Apr; 17(2):179-185. PubMed ID: 28685474
[TBL] [Abstract][Full Text] [Related]
9. Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer.
Hollis RL; Churchman M; Gourley C
Onco Targets Ther; 2017; 10():2539-2551. PubMed ID: 28546758
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
Rimar KJ; Tran PT; Matulewicz RS; Hussain M; Meeks JJ
Cancer; 2017 Jun; 123(11):1912-1924. PubMed ID: 28323334
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.
Xu K; Yang S; Zhao Y
Oncotarget; 2017 Jan; 8(1):285-302. PubMed ID: 27690218
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.
Biglia N; Sgandurra P; Bounous VE; Maggiorotto F; Piva E; Pivetta E; Ponzone R; Pasini B
Ecancermedicalscience; 2016; 10():639. PubMed ID: 27350785
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Sabatier R; Lavit E; Moretta J; Lambaudie E; Noguchi T; Eisinger F; Cherau E; Provansal M; Livon D; Rabayrol L; Popovici C; Charaffe-Jauffret E; Sobol H; Viens P
Fam Cancer; 2016 Oct; 15(4):497-506. PubMed ID: 26833043
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients.
Synowiec A; Wcisło G; Bodnar L; Górski B; Szenajch J; Szarlej-Wcisło K; Szczylik C
Hered Cancer Clin Pract; 2016; 14():1. PubMed ID: 26753012
[TBL] [Abstract][Full Text] [Related]
15. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
Nagle CM; Dixon SC; Jensen A; Kjaer SK; Modugno F; deFazio A; Fereday S; Hung J; Johnatty SE; ; Fasching PA; Beckmann MW; Lambrechts D; Vergote I; Van Nieuwenhuysen E; Lambrechts S; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Chang-Claude J; Goodman MT; Ness RB; Moysich K; Heitz F; du Bois A; Harter P; Schwaab I; Matsuo K; Hosono S; Goode EL; Vierkant RA; Larson MC; Fridley BL; Høgdall C; Schildkraut JM; Weber RP; Cramer DW; Terry KL; Bandera EV; Paddock L; Rodriguez-Rodriguez L; Wentzensen N; Yang HP; Brinton LA; Lissowska J; Høgdall E; Lundvall L; Whittemore A; McGuire V; Sieh W; Rothstein J; Sutphen R; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Webb PM;
Br J Cancer; 2015 Sep; 113(5):817-26. PubMed ID: 26151456
[TBL] [Abstract][Full Text] [Related]
16. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
[TBL] [Abstract][Full Text] [Related]
17. Role of BRCA1 and BRCA2 gene mutations in epithelial ovarian cancer in Indian population: a pilot study.
Sharma S; Rajaram S; Sharma T; Goel N; Agarwal S; Banerjee BD
Int J Biochem Mol Biol; 2014; 5(1):1-10. PubMed ID: 24955283
[TBL] [Abstract][Full Text] [Related]
18. The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.
Sun C; Li N; Ding D; Weng D; Meng L; Chen G; Ma D
PLoS One; 2014; 9(5):e95285. PubMed ID: 24788697
[TBL] [Abstract][Full Text] [Related]
19. Translational genomics in cancer research: converting profiles into personalized cancer medicine.
Patel L; Parker B; Yang D; Zhang W
Cancer Biol Med; 2013 Dec; 10(4):214-20. PubMed ID: 24349831
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
Lesnock JL; Darcy KM; Tian C; Deloia JA; Thrall MM; Zahn C; Armstrong DK; Birrer MJ; Krivak TC
Br J Cancer; 2013 Apr; 108(6):1231-7. PubMed ID: 23462720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
